Featured Research

from universities, journals, and other organizations

Secondhand Smoke Linked To Cervical Cancer

Date:
January 6, 2005
Source:
Johns Hopkins Bloomberg School Of Public Health And School Of Medicine
Summary:
Exposure to secondhand cigarette smoke increases the risk of developing cervical tumors, according to researchers at the Johns Hopkins Bloomberg School of Public Health and School of Medicine. The researchers’ results also corroborated past studies that found an association between active cigarette smoking and cervical neoplasia—the growth of a tumor.

Exposure to secondhand cigarette smoke increases the risk of developing cervical tumors, according to researchers at the Johns Hopkins Bloomberg School of Public Health and School of Medicine. The researchers’ results also corroborated past studies that found an association between active cigarette smoking and cervical neoplasia—the growth of a tumor. The concept of the Hopkins study was the result of collaboration between several researchers supported by the Maryland Cigarette Restitution Fund. The study is published in the January 2005 issue of Obstetrics & Gynecology.

“An association between active cigarette smoking and cervical cancer has been noted in numerous studies, but less is known about the potential link between passive smoking and the development of cervical neoplasia. When these new data for cervical cancer are considered in light of similar results from previously published studies, our findings suggest that passive smoking may be firmly linked with cervical cancer,” said Anthony J. Alberg, PhD, MPH, senior author of the study and an assistant professor in the Bloomberg School of Public Health’s Department of Epidemiology. “Our study of two large cohorts found that women who lived with smokers had a 40 percent or greater risk of developing cervical neoplasia.”

The Hopkins researchers examined the personal cigarette smoking and household passive smoking exposures of two Washington County, Md. , cohort groups in 1963 and 1975. Questionnaires from the two groups, which totaled 51,173 women, were compared to the Washington County cancer registry. The researchers found a stronger association between passive smoking and an increased risk for developing cervical neoplasia in the earlier cohort study—a 2.1-fold increased risk of cervical neoplasia in 1963 and a 1.4-fold increased risk in 1975.

“Public health researchers already knew that passive smoking increased heart disease and lung cancer. What we found in addition is that both active and passive smoking increases a woman’s risk for developing cervical neoplasia. Our study results are one more piece of evidence that should encourage smokers to quit and warn non-smokers who live with smokers to decrease their secondhand smoke exposure. Exposure to secondhand smoke can be reduced, and taking steps to reduce exposure may help to prevent cervical cancer,” said Dr. Alberg.

The study authors were supported in part by grants from the Maryland Cigarette Restitution Fund; National Institute of Aging; National Cancer Institute; National Institute of Environmental Health Sciences; and National Heart, Lung and Blood Institute.

Co-authors of the study from Johns Hopkins include Cornelia L. Trimble, MD; Jeanine M. Genkinger, PhD, MHS; Alyce E. Burke, MPH, Sandra C. Hoffman, MPH; Kathy J. Helzlsouer, MD, MHS; Marie Diener-West, PhD; George W. Comstock, MD, DrPH; Anthony J. Alberg, PhD, MPH.


Story Source:

The above story is based on materials provided by Johns Hopkins Bloomberg School Of Public Health And School Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Bloomberg School Of Public Health And School Of Medicine. "Secondhand Smoke Linked To Cervical Cancer." ScienceDaily. ScienceDaily, 6 January 2005. <www.sciencedaily.com/releases/2005/01/050106105740.htm>.
Johns Hopkins Bloomberg School Of Public Health And School Of Medicine. (2005, January 6). Secondhand Smoke Linked To Cervical Cancer. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2005/01/050106105740.htm
Johns Hopkins Bloomberg School Of Public Health And School Of Medicine. "Secondhand Smoke Linked To Cervical Cancer." ScienceDaily. www.sciencedaily.com/releases/2005/01/050106105740.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins